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Dendritic cell-tumor cell hybrids (heterokaryons) are
under investigation as a means for tumor immunotherapy
since they should express MHC class I molecules from
both cell types and, thus, present tumor antigens within
an immunogenic context. The aim of this work was, there-
fore, to evaluate, in vitro, the immunostimulatory potential
of these heterokaryons. To generate the hybrids, mature
dendritic cells (mDCs) differentiated from peripheral
blood of healthy donors were fused with cells from the
breast cancer cell line MDA-MB-231 by applying an elec-
tric pulse. The hybrids expressed both the tumor antigen
Her2 and the mDC marker CD11c (percentage of double-
positive cells; Mix: 2.4 ± 0.5; Fusion: 13.2 ± 3.0; p<0.0001;
n=8) and the molecules CD40, CD83, CD80 and CD86.
They also expressed more MHC class I molecules at their
surface (median fluorescence intensity; Mix: 17.8 ± 3.4;
Fusion: 33.2 ± 7.2; p<0.05; n=4) which was proved to be
due to the co-expression of molecules from both cell
types. When co-cultured with autologous T lymphocytes
for 5 days, the hybrids induced the same percentage of
T cells positive for Foxp3 and T-bet but a higher percen-
tage of GATA-3 positive T cells, when compared to the
mix. Intriguingly, the hybrids induced lower T cell prolif-
eration, when compared to the mix. However, when non-
fused mDCs were added to the co-culture, T cell activation
was significantly more intense than the sum of the activa-
tion induced by each cell type individually, as measured by
T cell proliferation (percentage of cells with CFSE dilution;
mDC: 9.7; Fusion: 6.3; mDC + Fusion: 47.8) and CD25
expression (percentage of positive cells; mDC: 9.9; Fusion:
9.7; mDC + Fusion: 57.4). Furthermore, addition of these
free mDC to co-culture also induced more T-bet positive
T cells. So, these data indicate that the induction/direction
of immune responses by dendritic-tumor cell hybrids may
be modified by the addition of non-fused DCs to the
preparation, a strategy that may have clinical relevance.
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